By Aidan Sowa, CEO and Founder, Frontier Industries | October 2026
Dermatology holds two reputations at once. It is the specialty that catches the deadliest common cancer early, and the specialty the internet treats as a beauty counter. A clinic communications programme has to serve the patient with a changing mole and the client with a wedding in June, without letting either audience mistake your priorities. This guide compares agency types against that dual workload, using published skin cancer data from federal sources. It is written for owners who refuse to choose between being taken seriously and being fully booked. You can be both. It requires an agency that knows which story it is telling.
Key numbers for this decision:
- 6.1 million: people treated for skin cancer in the United States each year (CDC, National Center for Chronic Disease Prevention and Health Promotion)
- 103,681: melanoma cases diagnosed in the United States in 2023, with 8,350 deaths (CDC Melanoma Dashboard)
- 8.9 billion dollars: annual medical cost of treating skin cancer in the United States (CDC)
I Discrimen
Serious medicine and aesthetic retail share your waiting room
The distinction that governs everything: your clinic sells vigilance and vanity out of the same diary. The vigilance side, skin checks, biopsies, Mohs surgery, chronic disease management, runs on clinical trust and referring physician confidence. The aesthetic side, injectables, lasers, peels, runs on photographs, seasonality and social proof. Agencies usually understand one side instinctively and fake the other.
The failure looks like this. A cosmetics fluent firm fills your channels with glow content while your skin cancer screening story, the one that earns local news coverage, hospital relationships and genuine public gratitude, goes untold. A medicine fluent firm produces worthy screening campaigns while your aesthetic rooms sit half empty beside a medspa that markets rings around you. Neither failure is a creative problem. Both are brief problems: nobody made the agency hold both audiences in one plan.
Two diaries, two promises, one standard of evidence. That sentence should be taped above the desk of whoever you hire.
Test it directly. Ask finalists to outline a year in which May is skin cancer awareness month and your aesthetic practice launches a new laser in September. Watch whether one calendar serves both without tonal whiplash. The firm that can sequence seriousness and celebration is the firm that understands your building.
II Machina
Access is your scarcest product, and your story must manage the queue
Dermatology access is a public story in itself: demand for skin checks and cosmetic consultations chronically exceeds the supply of board certified dermatologists, and patients experience your specialty as a waiting list. That scarcity shapes communications in ways agencies rarely price in. Marketing that works too well on the wrong segment creates queues that damage the medical reputation, while patients with urgent lesions compete for slots with patients seeking elective glow.
The mechanism to manage is triage storytelling. Your public content should teach the market what needs speed, a changing or bleeding mole, a non healing sore, and what can wait, routine cosmetic consultations, so demand sorts itself before it reaches your phones. Agencies that understand health care will propose exactly this: education as queue management. Agencies that do not will sell you demand generation and leave your reception team to absorb the consequences in public reviews complaining about waits you manufactured.
Scarcity also changes what a good story is worth. When every dermatology clinic in the region has a waiting list, patients choose on perceived honesty about access as much as on brilliance. The clinic that publishes its real wait times, explains its urgent slot system and tells cosmetic patients plainly where they sit in the queue earns a kind of trust advertising cannot simulate. Agencies allergic to operational detail will resist this, because it requires them to learn your diary before writing a word. That resistance is diagnostic. The firms worth hiring ask for your access data in the first meeting and build the story out of it.
A queue explained is a reputation. A queue discovered is a scandal. The difference is whether your communications taught patients what to expect before they needed you.
Judge proposals on whether they mention access at all. Silence on the subject means the firm has never run a scarce specialty, whatever its beauty credentials.
III Exemplum
Melanoma is the case for taking your medical voice seriously
In 2023, 103,681 people in the United States were diagnosed with melanoma and 8,350 died of it (CDC Melanoma Dashboard). The CDC estimates 6.1 million people are treated for skin cancer of all kinds each year at a cost of about 8.9 billion dollars (CDC). Behind those numbers sits the most favourable fact in your specialty: caught early, skin cancer is among the most treatable of cancers, and dermatologists are the people who catch it.
This is why local newsrooms call dermatology clinics every spring, and why the clinics that answer well own a public position no medspa can buy. The dermatologist who explains screening on camera, who runs the free screening day the paper photographs, who comments carefully when a celebrity melanoma story breaks, becomes the region clinical conscience on skin. That position fills medical diaries directly and aesthetic diaries by halo, because patients reason, correctly, that the doctor trusted with cancer can be trusted with a laser.
An agency that treats this as seasonal filler misunderstands your asset base. The screening story is not corporate social responsibility. It is the foundation asset of the whole practice reputation, and the aesthetic programme is built on its credibility. Choose the firm that plans May with the same seriousness as the September launch.
IV Damnum
Where dermatology reputations actually bleed
Not in cancer care, where gratitude dominates, but in the seams. The cosmetic patient who feels sold a package she did not need. The medical patient who waited four months and was seen for ninety seconds. The biopsy result communicated late or clumsily. The social post where a provider mocks a skin condition for engagement. Each bleeds trust in the segment where your margins live, and each is a communications failure before it is a clinical one, because expectations were set by your marketing and met by nobody.
There is a regulatory seam too. Skincare claims are advertising claims, and regulators treat miracle language about lasers, serums and devices as a compliance question, not a creative one. Clinics inherit the claims their agencies write. A firm casual about substantiation will eventually write a sentence your balance sheet has to defend, in a market where competitors screenshot everything.
Staff conduct is the seam nobody budgets for. Dermatology teams see bodies at their most unguarded, and a single flippant remark repeated online, a photograph taken where no photograph should exist, or a dismissive reply to an anxious patient can define a clinic faster than a decade of screening work. Communications training for front desk and clinical support staff sounds like an agency upsell until the first incident. Then it reads as the cheapest insurance the practice never bought. Include staff training scope in the brief and in the contract, with names and hours, or accept that your most public employees are your least prepared ones.
Price the seams into your choice. The cheapest agency is the one whose content you never have to apologise for, retract or explain to a board investigator. In dermatology the apology tour is especially expensive, because it runs in front of the same local audience your aesthetic growth depends on.
V Genus
The agency types, mapped to a two diary clinic
| Agency type | Medical dermatology fit | Aesthetic dermatology fit |
|---|---|---|
| Healthcare PR firm | Strong: screening campaigns, referral confidence, crisis steadiness | Weak to fair: can underplay seasonality and social craft |
| Beauty and wellness agency | Weak: tends to trivialise cancer and chronic disease | Strong: launches, creators, retail rhythm |
| Dermatology or aesthetic specialist | Good: knows Mohs from microdermabrasion | Good: knows device launches and claim limits |
| Local generalist agency | Fair: community presence and local media | Fair: steady content, limited platform instinct |
| Digital performance firm | Fair: access and booking funnel discipline | Fair to strong: conversion focused creative |
Most mature clinics end with a lead firm from row one or three and strict claims oversight across everything. The dangerous hire is row two alone, given a whole clinic to run: within a year your public identity tilts cosmetic, referring physicians quietly downgrade you, and rebuilding the medical reputation costs multiples of the saving.
Ask each finalist which diary they would fill first and watch for contempt. Contempt for the medical diary or for the aesthetic one predicts the failure you will spend the contract managing.
VI Regio
Segment by condition and by intent, not by service list
Your market is at least four publics. The screening public: older patients and the worried well, reached through local news, community events and search. The chronic disease public: psoriasis, eczema and acne patients who need long term trust and education, and who punish hype fastest. The aesthetic public: event driven, social led, price aware. The referring public: primary care physicians who need your access and reporting to make them look good to their patients.
Each public accepts different proof. Screening wants credentials and outcomes. Chronic disease wants empathy with evidence. Aesthetic wants photographs with consent and honest recovery accounts. Referrers want turnaround times and letters that arrive. An agency plan that does not name these four and resource them separately is a service list wearing a strategy costume.
Geography tunes the mix. Sun belt clinics carry a heavier screening duty and a year round aesthetic season. Northern clinics run a compressed cosmetic calendar and a spring screening surge. Buy the firm whose plan matches your latitude, not the firm with the prettiest national case studies from a different climate.
VII Occasio
The opening is authority: nobody else can say what your doctors can say
Skin is the most photographed organ and the least understood, and the information market is flooded with confident nonsense: miracle ingredients, dangerous home treatments, sunscreen fear content. A board certified dermatologist explaining, in plain language, what the evidence supports is a genuinely scarce public good. Clinics that supply it consistently become the local reference, and reference status compounds: journalists call, schools invite, employers ask about screening days, and patients arrive pre persuaded.
The equaliser is that a two physician clinic can do this as well as a university department, because the camera and the search box reward clarity, not headcount. What it requires is system: one clinical topic a fortnight, one screening story a season, claims checked against American Academy of Dermatology guidance, and a dermatologist protected from content duties beyond an hour or two a month.
Ask finalists for their editorial system, not their content ideas. Ideas are infinite and cheap. A system that survives a flu outbreak in your diary and a holiday month is the actual product.
Protect the system from its own success. Authority content attracts patient questions by message and comment, and every answer edges toward individual medical advice. A disciplined agency builds the guardrails with you: standard replies that route questions to appointments, a hard rule against diagnosing from photographs, and a named clinician who reviews anything clinical before it posts. The clinics that get hurt online are rarely the ignorant ones. They are the helpful ones, answering one question too many.
VIII Consilium
The decision scorecard for dermatology
| Criterion | Weight | What to inspect |
|---|---|---|
| Dual diary fluency | 25 percent | A one year plan serving screening and aesthetics without whiplash |
| Claims substantiation discipline | 20 percent | Written rules for device, product and outcome claims |
| Access and triage storytelling | 20 percent | Content that teaches urgency and manages the queue |
| Referrer communications | 15 percent | A plan for primary care confidence, not only patient marketing |
| Clinical voice building | 10 percent | Examples of physicians they have made into public authorities |
| Crisis readiness | 10 percent | Response plan for a safety or conduct story |
Contract for a year with a claims protocol attached, image consent rules in writing, and quarterly reviews against outcomes in both diaries: screening bookings and aesthetic consultations reported side by side, so neither side of the clinic can quietly eat the other. The public relations services structure used by one specialist team is a useful comparison, and the neighbouring guides to plastic surgery clinics and medical spas sit in the same resources library.
Frequently asked questions
How do we market skin cancer screening without scaring patients?
Teach signs, not fear. Content built on what a changing mole looks like, who should be checked and how simple a check is will outperform alarm every time, and it serves the public while it fills the diary. Your dermatologists should front it, and your agency should time it to spring and to local news interest, not to a retail calendar.
Can we promote cosmetic treatments and medical care on the same social account?
Yes, with disciplined separation. Label content clearly, keep clinical claims to the standard of the medical diary, and never let a promotional post sit where a worried patient lands first. Many clinics run one account with a firm editorial calendar; the failures come from improvisation, not from sharing the account.
What claims can we make about lasers and skincare products?
Only claims you can substantiate, phrased as what a treatment can do for suitable patients, not what it will do for the reader. Device and product claims are regulated advertising, and your agency should hold a substantiation file for every claim it publishes. If a sentence sounds like a miracle, it is a liability wearing perfume.
Should we offer free screening days?
If you run them, run them properly: enough clinicians, a clear follow up pathway for anything found, and honest communication about capacity. A screening day that discovers lesions it cannot schedule is a reputation injury. Done well, it is the single most trusted act a dermatology clinic performs in public.
How do we handle a provider posting questionable content personally?
With a written social policy agreed before the incident, covering clinical claims, patient images and conditions mocked for humour. Agencies should help draft it and train to it. Discipline after the fact is a management matter; prevention beforehand is a communications one, and it is cheaper.
How long before authority content changes bookings?
Screening authority tends to move bookings within one season because local media and search amplify it quickly. Aesthetic authority compounds over six to twelve months as content accumulates. Expect the medical diary to respond first and use that early win to fund patience on the cosmetic side.
How this guide was built
This guide is grounded in CDC skin cancer data and prevention resources, American Academy of Dermatology public education positions, and Federal Trade Commission advertising guidance, listed below. Dermatology practice structures vary, from physician owned clinics to platform groups, and state advertising rules differ; the framework is a decision aid, and live claims should always be checked against current guidance and your own counsel.
IX Incipe
Where Frontier Industries fits
Frontier Industries runs dermatology accounts as two diary practices with one evidence standard: screening authority built like a public duty, aesthetic growth built like a business, and a claims file behind every sentence. You can meet the people behind that approach on the about page.
If your clinic is choosing now, bring your access numbers and your last quarter of content to one structured conversation: start an industry campaign enquiry or call 401-219-4207.
Sources
1. CDC, Health and economic benefits of skin cancer interventions, including 6.1 million people treated yearly and 8.9 billion dollars in costs. https://www.cdc.gov/nccdphp/priorities/skin-cancer.html 2. CDC, Melanoma Dashboard, incidence and mortality data including 2023 diagnoses. https://ephtracking.cdc.gov/Applications/melanomadashboard/a 3. US Surgeon General and HHS, Skin Cancer: Quick Facts, on prevalence and prevention. https://www.hhs.gov/surgeongeneral/reports-and-publications/skin-cancer/fact-sheet/index.html 4. American Academy of Dermatology, public education on skin cancer detection and sun protection. https://www.aad.org/public 5. Federal Trade Commission, Health Products Compliance Guidance on substantiating advertising claims. https://www.ftc.gov/legal-library/browse/federal-register-notices/health-products-compliance-guidance 6. HHS Office for Civil Rights, HIPAA guidance relevant to patient images and marketing authorisation. https://www.hhs.gov/hipaa/index.html 7. KFF, Trust in health information, doctors the most trusted source, 2025. https://www.kff.org/health-information-trust/new-kff-poll-shows-public-divided-when-it-comes-to-trusting-federal-health-agencies-for-reliable-information/ 8. American Society of Plastic Surgeons, 2023 procedural statistics on minimally invasive aesthetic growth. https://www.plasticsurgery.org/news/press-releases/plastic-surgery-sees-steady-growth-amidst-economic-uncertainty-american-society-of-plastic-surgeons-2023-procedural-statistics-report-finds 9. Press Ganey, Patient experience research for specialty and ambulatory practices. https://www.pressganey.com/resources/ 10. Edelman, Trust Barometer, health sector findings. https://www.edelman.com/trust-barometer